Operating Lease, Right-of-Use Asset of NeuroSense Therapeutics Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NeuroSense Therapeutics Ltd. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
  • NeuroSense Therapeutics Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $42,000, a 66% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NeuroSense Therapeutics Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $42,000 -$81,000 -66% 30 Jun 2025 6-K 01 Aug 2025 2025 Q2
Q4 2024 $84,000 -$78,000 -48% 31 Dec 2024 6-K 01 Aug 2025 2025 Q2
Q2 2024 $123,000 30 Jun 2024 6-K 30 Sep 2024 2024 Q2
Q4 2023 $162,000 -$74,000 -31% 31 Dec 2023 20-F 07 Apr 2025 2024 FY
Q4 2022 $236,000 31 Dec 2022 6-K 17 Jun 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.